In RA patients, aβ2GPI‐IgA was significantly more frequent than aβ2GPI‐IgG (26.7% vs 6.7%, P = .0003) and aβ2GPI‐IgM (26.7% vs 5.6%, P = .0001). The gene discussed is CD79A; the disease is rheumatoid arthritis.